Biomedical sciences
SRI Biosciences delivers next-generation drugs, diagnostics and devices to solve unmet medical needs. We work with partners to develop transformative approaches and platforms for the toughest therapeutic problems.
Our innovation strategies are built on more than 50 years of drug development and discovery experience. We’ve refined our ability to repeat biomedical discovery and catalyze innovation into new products.
Ian M. Colrain
President, Biosciences Division
Some of our innovators
Areas of expertise
Collaborative research
- Neuroimaging and electrophysiological research
- Sleep device design and validation
- Adolescent development
- Translational approaches using in vivo MRI
- Translational neuroscience
Drug discovery
- Technology platforms for new approaches to drug discovery
- Small molecule and biologic therapies
- AI-driven drug design
- Target validation and assay development and screening
- Lead identification, optimization and synthesis
Diagnostics and devices
- Fiber-optic Array Scanning Technology (FAST) rare cell detection
- High-speed hyperspectral imaging
- Wearable sleep technology
- Diagnostic biomarker discovery
- SynFini: automated chemistry design and synthesis
- Chemical and biological sensing solutions
Product development services
- Pharmacology, efficacy and predictive ADMET
- Safety, drug metabolism and pharmacokinetics
- Formulation design
- Clinical drug product manufacturing
- Clinical trials
Fields of research
We work with commercial, government and academic clients and partners to help save and improve lives worldwide. Our leading-edge R&D is concentrated in the following areas to solve important problems in prevention, diagnosis and treatment.
Human sleep
Aging and neurodegenerative diseases
Neuroimaging and electrophysiological research
Blood brain barrier transport
Toxicology and safety
Homeland security/national defense
Immuno-oncology
Intracellular biologic therapies
Medical countermeasures
Formulation design
Biomarker discovery, development, validation
There are many talented researchers from various disciplines at SRI. This creates an exciting environment and fertile ground for cutting edge research thanks to the cooperation of different teams. This highly effective collaboration allows SRI to invent and develop unique and novel products and technologies.
Michal Avital-Shmilovici
Research Scientist, Biosciences Division
Featured publications
Modular Three-Component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-Cell Activation against Tumors
SRI Authors: Feng Wang-Johanning, Gary L. Johanning
Article February 1, 2015
How can we help?
Once you hit send…
We’ll match your inquiry to the person who can best help you. Expect a response within 48 hours.
